Pharmacodiversity Oriented Synthesis: A New Tool For The Rapid Discovery Of Treatment For Multidrug-Resistant Bacteria

The threat posed by drug-resistant bacteria and other microbes is increasing as new strains emerge. Yet, major pharmaceutical companies are not seeking new drugs to fight back. Dr. Andrew Silvanus is developing a faster, easier method of screening candidates for potential new “superdrugs”: starting with natural substances containing molecular structures already known to fight infection, tweaking them in a variety of ways, and testing the results. Silvanus's work has the potential to accelerate vital antibiotic discovery.